John W. Creemers
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
The Role of Furin in Hallmarks of Aneurysms: A Focus On Its Substrates.
Journal: Current atherosclerosis reports
Published: January 04, 2026
Furin-like enzyme dependency in KRAS-mutant colorectal cancer as a target for personalized treatment strategies.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: December 19, 2025
Furin sustains tumor-promoting signals in KRAS- and BRAF-mutated colorectal cancer by engaging the TGF-β1-COX-2 axis in a reciprocal regulatory network.
Journal: Oncogene
Published: September 16, 2025
Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.
Journal: Blood
Published: July 01, 2025
Similar metabolic pathways are affected in both Congenital Myasthenic Syndrome-22 and Prader-Willi Syndrome.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 18, 2023
Unveiling the oncogenic role of LZTS1 in colorectal cancer.
Journal: Journal of cellular and molecular medicine
Published: November 15, 2023
Epigenetic modulations of immune cells: from normal development to tumor progression.
Journal: International journal of biological sciences
Published: July 21, 2023
The proprotein convertase FURIN is a novel aneurysm predisposition gene impairing TGF-β signalling.
Journal: Cardiovascular research
Published: May 31, 2023
Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation.
Journal: Blood
Published: October 26, 2022
Last Updated: 09/26/2026